View in EDS

Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma.

Saved in:

Bibliographic Details
Title:	Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma.
Authors:	Wu, Liangliang^1,2 (AUTHOR), Ge, Yi¹ (AUTHOR), Yuan, Yudong¹ (AUTHOR), Li, Hui¹ (AUTHOR), Sun, Huizhi¹ (AUTHOR), Xu, Chao¹ (AUTHOR), Wang, Yifei¹ (AUTHOR), Zhao, Tiansuo¹ (AUTHOR), Wang, Xiuchao¹ (AUTHOR), Liu, Jing^1,3 (AUTHOR), Gao, Song¹ (AUTHOR), Chang, Antao¹ (AUTHOR) changantao@tjmuch.com, Hao, Jihui¹ (AUTHOR) haojihui@tjmuch.com, Huang, Chongbiao¹ (AUTHOR) chhuang@tmu.edu.cn
Source:	Cancer Letters. Nov2022, Vol. 548, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	03043835
DOI:	10.1016/j.canlet.2022.215864